Pliant Therapeutics, Inc. (PLRX) Financials
PLRX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 512.2 million | 38.6 million |
| 2023-09-30 | 540.5 million | 37.4 million |
| 2023-06-30 | 574.9 million | 41.8 million |
| 2023-03-31 | 597.9 million | 36.0 million |
PLRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -25.2 million | 9.2 million |
| 2023-09-30 | -36.3 million | 10.4 million |
| 2023-06-30 | -25.4 million | 13.0 million |
| 2023-03-31 | -30.4 million | 11.9 million |
PLRX Net Income
No data available :(
PLRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 494.2 million | - | 1.3 million |
| 2023-09-30 | 523.6 million | - | 2.1 million |
| 2023-06-30 | 555.2 million | 10.0 million | 4.6 million |
| 2023-03-31 | 577.3 million | 10.0 million | 5.2 million |
PLRX Shares Outstanding
PLRX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 61000 | 32.7 million | 13.9 million | - |
| 2023-09-30 | 94000 | 32.3 million | 15.3 million | - |
| 2023-06-30 | 603000 | 33.0 million | 14.6 million | - |
| 2023-03-31 | 163000 | 29.3 million | 14.2 million | - |
PLRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 4.8 million | 464000 |
| 2023-09-30 | - | 1.0 million |
| 2023-06-30 | 248000 | 1.1 million |
| 2023-03-31 | 1.3 million | 1.1 million |
PLRX
Price: $12.28
52 week price:
Earnings Per Share: -2.75 USD
P/E Ratio: -5.74
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.0 million
Market Capitalization: 852.4 million